L5W Stock Overview
Develops and markets instrumentation for non-invasive time-lapse imaging in Sweden and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Phase Holographic Imaging PHI AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.54 |
| 52 Week High | SEK 0.75 |
| 52 Week Low | SEK 0.32 |
| Beta | 1.12 |
| 11 Month Change | -15.00% |
| 3 Month Change | -11.97% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -16.69% |
Recent News & Updates
Recent updates
Shareholder Returns
| L5W | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -13.1% | 0.5% | -0.1% |
| 1Y | n/a | 0.9% | 2.4% |
Return vs Industry: Insufficient data to determine how L5W performed against the German Medical Equipment industry.
Return vs Market: Insufficient data to determine how L5W performed against the German Market.
Price Volatility
| L5W volatility | |
|---|---|
| L5W Average Weekly Movement | 19.2% |
| Medical Equipment Industry Average Movement | 4.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: L5W's share price has been volatile over the past 3 months.
Volatility Over Time: L5W's weekly volatility (19%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 13 | Patrik Eschricht | www.phiab.se |
Phase Holographic Imaging PHI AB (publ) develops and markets instrumentation for non-invasive time-lapse imaging in Sweden and internationally. The company’s products include HoloMonitor M4, a live cell imaging microscope system; HoloMonitor M3, a bench-top time-lapse cytometer equipped with a motorized stage and variable magnification; HoloMonitor app Suite for cell imaging software facilitates kinetic live-cell tracking and analysis; HoloMonitor M4FL, a system for fluorescence; and HoloMonitor single tracking, kinetic dose response and cell mobility, cell morphology, wound healing, cell quality control, cell control, and kinetic cell proliferation assay. It offers HoloLids to eliminate image disturbances caused by surface vibrations and condensation inside the cell culture vessel; Vessel Holder to fix the culture vessel to the motorized stage; and HoloDry to keep optics for condensation of HoloMonitor free.
Phase Holographic Imaging PHI AB (publ) Fundamentals Summary
| L5W fundamental statistics | |
|---|---|
| Market cap | €14.85m |
| Earnings (TTM) | -€20.17m |
| Revenue (TTM) | €10.51m |
0.0x
P/S Ratio0.0x
P/E RatioIs L5W overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| L5W income statement (TTM) | |
|---|---|
| Revenue | SEK 10.51m |
| Cost of Revenue | SEK 3.07m |
| Gross Profit | SEK 7.44m |
| Other Expenses | SEK 27.61m |
| Earnings | -SEK 20.17m |
Last Reported Earnings
Apr 30, 2024
Next Earnings Date
Sep 16, 2024
| Earnings per share (EPS) | -0.77 |
| Gross Margin | 70.78% |
| Net Profit Margin | -191.96% |
| Debt/Equity Ratio | 360.9% |
How did L5W perform over the long term?
See historical performance and comparison